Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Nehal A Khalil"'
Publikováno v:
Heliyon, Vol 9, Iss 11, Pp e22374- (2023)
Externí odkaz:
https://doaj.org/article/e4309ac46bfa4530871f9b539b58f98d
Publikováno v:
Talanta Open, Vol 7, Iss , Pp 100219- (2023)
Durvalumab (DUR) is a human monoclonal antibody used for the immunotherapy of lung cancer. It is a novel immune-checkpoint inhibitor, which blocks the programmed death 1 (PD-1) and programmed death-ligand 1 (PD-L1) proteins and works to promote the n
Externí odkaz:
https://doaj.org/article/a236c263cfb44d009f541ecabc987aa1
Publikováno v:
Heliyon, Vol 9, Iss 6, Pp e15782- (2023)
Durvalumab (DUR) is a human monoclonal antibody used for the immunotherapy of lung cancer. It is a novel immune-checkpoint inhibitor, which blocks the programmed death 1 (PD-1) and programmed death-ligand 1 (PD-L1) proteins and works to promote the n
Externí odkaz:
https://doaj.org/article/09edd52072254ba8a415bd055ec23640
Publikováno v:
Chemosensors, Vol 11, Iss 4, p 245 (2023)
The development and validation of a novel enhanced chemiluminescence enzyme immunoassay (CLEIA) with excellent sensitivity for the quantification of monoclonal antibodies (mAbs) used for immunotherapy of cancer are described in this paper for the fir
Externí odkaz:
https://doaj.org/article/bc294d680cdd4c0c9d6cd10376a265b5
Autor:
Sahar A. Harby, Nehal A. Khalil, Norhan S. El-Sayed, Eman H. Thabet, Samar R. Saleh, Mona Hassan Fathelbab
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology.
Blood–brain barrier (BBB) efflux transporters' overexpression hinders antiepileptic drug brain entry. Breast cancer resistance protein (BCRP) is a major BBB efflux transporter. In the present work, BCRP's role as a mechanism that might contribute t
Autor:
Radwa A Mehanna, Marwa M Essawy, Mona A Barkat, Ashraf K Awaad, Eman H Thabet, Heba A Hamed, Hagar Elkafrawy, Nehal A Khalil, Abeer Sallam, Marwa A Kholief, Samar S Ibrahim, Ghada M Mourad
Publikováno v:
World Journal of Stem Cells
Regenerative medicine is the field concerned with the repair and restoration of the integrity of damaged human tissues as well as whole organs. Since the inception of the field several decades ago, regenerative medicine therapies, namely stem cells,
Autor:
Nehal L. Khalil
Publikováno v:
Sustainable Development Goals Series ISBN: 9783031106750
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::941024cd2163db54a6206eb7c96c35e9
https://doi.org/10.1007/978-3-031-10676-7_14
https://doi.org/10.1007/978-3-031-10676-7_14
Publikováno v:
Indian J Hematol Blood Transfus
Imatinib Mesylate is the drug used for targeted tyrosine kinase inhibition in the beginning of management of all Chronic Myeloid Leukemia (CML) newly diagnosed cases. However, resistance presents a considerable limit to its efficacy. Currently, it is
Publikováno v:
Luminescence : the journal of biological and chemical luminescence. 32(7)
A new simple stability-indicating spectrofluorimetric method has been developed and validated for the determination of the tyrosine kinase inhibitor, linifanib (LNF). The proposed method makes use of the native fluorescence characteristics of LNF in
Autor:
Nehal Lotfy Khalil
Publikováno v:
Discourse and Communication for Sustainable Education, Vol 3, Iss 2012, Pp 109-120 (2012)
Due to the rapidly changing knowledge, teachers are supposed to teach their students ways of thinking and gathering information, not certain contents that would change shortly. In this sense, sustainability, which, in part, means the preparation of a